Literature DB >> 24128612

Prevalent combination of virulence and plasmidic-encoded resistance in ST 131 Escherichia coli strains.

Vera Calhau1, Graça Ribeiro2, Nuno Mendonça3, Gabriela Jorge Da Silva3.   

Abstract

Escherichia coli ST131 is an important cause of multidrug-resistant infections. Thus, the aim of this study was to evaluate the concomitant presence of resistance plasmids and pathogenicity islands (PAIs) in ST131 E. coli. From 97 extraintestinal E. coli characterized for antimicrobial susceptibility and extended-spectrum β-lactamase production, 16% of isolates were identified as CTX-M-15 producers. These strains were studied by PFGE, MLST, and phylogroups, plasmid groups, PAIs, and plasmid-mediated quinolone-resistance determinants. MLST identified one ST10 strain from phylogroup A and the remaining isolates were ST131, from group B2. Despite the genetic variability, 64% of ST131 strains presented a profile composed by PAI IV₅₃₆, PAI I(CFT073), and PAI II(CFT073), IncF plasmid, bla(CTX-M-15), and aac(6')-lb-cr genes. The prevalent virulence and resistance profile detected among the strains may constitute an optimal combination of factors, which allow E. coli ST131 to maintain both features becoming concomitantly virulent and extremely resistant.

Entities:  

Keywords:  CTX-M-15; Escherichia coliST131; PMQR; pathogenicity island; phylogeny; plasmid replicon typing

Mesh:

Substances:

Year:  2013        PMID: 24128612      PMCID: PMC3925704          DOI: 10.4161/viru.26552

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  15 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors:  Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

Review 3.  Resistance plasmid families in Enterobacteriaceae.

Authors:  Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

4.  High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.

Authors:  Junying Ma; Zhenling Zeng; Zhangliu Chen; Xiaogang Xu; Xiaoying Wang; Yuting Deng; Dianhong Lü; Liangzong Huang; Yunyuan Zhang; Jianhua Liu; Minggui Wang
Journal:  Antimicrob Agents Chemother       Date:  2008-10-20       Impact factor: 5.191

5.  Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Authors:  Nuno Mendonça; Joana Leitão; Vera Manageiro; Eugénia Ferreira; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

6.  Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates.

Authors:  M Sabaté; E Moreno; T Pérez; A Andreu; G Prats
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

7.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

8.  Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.

Authors:  Vincent Cattoir; Laurent Poirel; Vincent Rotimi; Claude-James Soussy; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2007-06-08       Impact factor: 5.790

9.  Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131.

Authors:  Jean-Philippe Lavigne; Annette C Vergunst; Lucie Goret; Albert Sotto; Christophe Combescure; Jorge Blanco; David O'Callaghan; Marie-Hélène Nicolas-Chanoine
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

10.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

View more
  11 in total

1.  Genomic and Functional Analysis of Emerging Virulent and Multidrug-Resistant Escherichia coli Lineage Sequence Type 648.

Authors:  Katharina Schaufler; Torsten Semmler; Jukka Corander; Sebastian Guenther; Lothar H Wieler; Darren J Trott; Johann Pitout; Gisele Peirano; Jonas Bonnedahl; Monika Dolejska; Ivan Literak; Stephan Fuchs; Niyaz Ahmed; Mirjam Grobbel; Carmen Torres; Alan McNally; Derek Pickard; Christa Ewers; Nicholas J Croucher
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

3.  Plasmids shape the diverse accessory resistomes of Escherichia coli ST131.

Authors:  Arun Gonzales Decano; Nghia Tran; Hawriya Al-Foori; Buthaina Al-Awadi; Leigh Campbell; Kevin Ellison; Louisse Paolo Mirabueno; Maddy Nelson; Shane Power; Genevieve Smith; Cian Smyth; Zoe Vance; Caitriona Woods; Alexander Rahm; Tim Downing
Journal:  Access Microbiol       Date:  2020-11-18

4.  Carriage of Extended-Spectrum Beta-Lactamase-Plasmids Does Not Reduce Fitness but Enhances Virulence in Some Strains of Pandemic E. coli Lineages.

Authors:  Katharina Schaufler; Torsten Semmler; Derek J Pickard; María de Toro; Fernando de la Cruz; Lothar H Wieler; Christa Ewers; Sebastian Guenther
Journal:  Front Microbiol       Date:  2016-03-17       Impact factor: 5.640

Review 5.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

6.  Tracking bacterial virulence: global modulators as indicators.

Authors:  Alejandro Prieto; Imanol Urcola; Jorge Blanco; Ghizlane Dahbi; Maite Muniesa; Pablo Quirós; Linda Falgenhauer; Trinad Chakraborty; Mário Hüttener; Antonio Juárez
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

7.  Complete Assembly of Escherichia coli Sequence Type 131 Genomes Using Long Reads Demonstrates Antibiotic Resistance Gene Variation within Diverse Plasmid and Chromosomal Contexts.

Authors:  Arun Gonzales Decano; Catherine Ludden; Theresa Feltwell; Kim Judge; Julian Parkhill; Tim Downing
Journal:  mSphere       Date:  2019-05-08       Impact factor: 4.389

8.  Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. coli ST131 and non-ST131 isolates from Iran.

Authors:  Zoya Hojabri; Narges Darabi; Maedeh Arab; Fereshteh Saffari; Omid Pajand
Journal:  BMC Microbiol       Date:  2019-05-30       Impact factor: 3.605

9.  A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.

Authors:  Stefan E Heiden; Nils-Olaf Hübner; Jürgen A Bohnert; Claus-Dieter Heidecke; Axel Kramer; Veronika Balau; Wolfgang Gierer; Stephan Schaefer; Tim Eckmanns; Sören Gatermann; Elias Eger; Sebastian Guenther; Karsten Becker; Katharina Schaufler
Journal:  Genome Med       Date:  2020-12-09       Impact factor: 11.117

10.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.